Bristol Health Partners 10th anniversary conference gets delegates moving
Bristol Health Partners Academic Health Science Centre welcomed more than 100 delegates to our…
Kidney Disease HIT reviews 2021-22
In June 2021, we welcomed Pippa Bailey, Consultant Senior Lecturer at the University of Bristol,…
University of Bristol to collaborate with Evotec to help treatment of kidney diseases
A new collaboration to help patients with nephrotic syndrome, a type of kidney disease, has…
Connie Shiridzinomwa and Heidi Andrews join Bristol Health Partners team
Our team welcomed two new members at the end of 2021 and start of 2022…
Bristol Health Partners conference puts lived experience at heart of health research
Bristol Health Partners held its annual Conference on Tuesday 12 October 2021. Like last year,…
Kidney Disease HIT's 2020-21 update
Dominic Taylor, Director of the Kidney Disease HIT, shares an update on the team’s…
Bristol University secures £45M to advance gene therapy treatment of chronic kidney diseases
Purespring Therapeutics will become one of the first kidney gene therapy companies The University…
2019-20 Kidney Disease HIT achievements
Kidney Disease (formerly known as Chronic Kidney Disease) Health Integration Team Director…
HITs secure £2.9 million in research funding in 2018-19
Bristol Health Partners Health Integration Teams (HITs) have attracted nearly £2.9 million in research funding…
Chronic Kidney Disease HIT tele-clinics proof of concept published in BMJ Open
The Chronic Kidney Disease HIT has published its proof of concept study for tele-clinics for…
Activities of the Chronic Kidney Disease HIT in 2018-19
Dr Fergus Caskey gives an update on the work of the Chronic Kidney Disease Health…